From: Categorisation of foot complaints in systemic lupus erythematosus (SLE) from a New Zealand cohort
Characteristic | Value |
---|---|
Female sex, n (%) | 87 (93.7) |
Age (years), mean (SD) | 50.4 (14.3) |
Disease duration (years), mean (SD) | 13.1 (11) |
BMI (kg/m2), mean (SD) | 28.2 (6.6) |
Current smoker, n (%) | 20 (21) |
Employment status, n (%) | |
Paid work | 51 (53) |
Not working | 21 (23) |
Retired | 14 (16) |
Unpaid work | 5 (6) |
Sick leave | 1 (1) |
Full-time education | 1 (1) |
Ethnicity, n (%) | |
New Zealand European | 47 (51) |
Pacific Island | 17 (19) |
Asian | 13 (14) |
Māori | 8 (9) |
Chinese | 5 (6) |
Afro-carribean | 1 (1) |
Medication use a | |
Hydroxychloroquine, n (%) | 75 (81) |
Azathioprine, n (%) | 18 (19) |
Methotrexate, n (%) | 16 (17) |
Mycophenolate, n (%) | 4 (4) |
Cyclophosphamide, n (%) | 2 (2) |
Oral glucocorticoid use, n (%) | 43 (46) |
Non-steroidal anti-inflammatory drug use, n(%) | 26 (28) |
Rituximab use, n (%) | 5 (6) |